EUVIMEDEUVIMED entdecken
Open Access

Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant

Ruchi Sharma, Wenzhe Zang, Ali Tabartehfarahani, Andres Lam, Xiaheng Huang, Anjali Devi Sivakumar, Chandrakalavathi Thota, Shuo Yang, Robert P Dickson, Michael W Sjoding, Erin Bisco, Carmen Colmenero Mahmood und 5 weitere

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.0982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von Ruchi Sharma und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Michigan, Ann Arbor. Hauptthemen laut MEDLINE: COVID-19, Volatile Organic Compounds. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Breath analysis has been explored as a noninvasive means to detect COVID-19. However, the impact of emerging variants of SARS-CoV-2, such as Omicron, on the exhaled breath profile and diagnostic accuracy of breath analysis is unknown.

Objective

To evaluate the diagnostic accuracies of breath analysis on detecting patients with COVID-19 when the SARS-CoV-2 Delta and Omicron variants were most prevalent. Design, Setting, and Participants This diagnostic study included a cohort of patients who had positive and negative test results for COVID-19 using reverse transcriptase polymerase chain reaction between April 2021 and May 2022, which covers the period when the Delta variant was overtaken by Omicron as the major variant. Patients were enrolled through intensive care units and the emergency department at the University of Michigan Health System. Patient breath was analyzed with portable gas chromatography. Main Outcomes and Measures Different sets of VOC biomarkers were identified that distinguished between COVID-19 (SARS-CoV-2 Delta and Omicron variants) and non–COVID-19 illness.

Results

Overall, 205 breath samples from 167 adult patients were analyzed. A total of 77 patients (mean [SD] age, 58.5 [16.1] years; 41 [53.2%] male patients; 13 [16.9%] Black and 59 [76.6%] White patients) had COVID-19, and 91 patients (mean [SD] age, 54.3 [17.1] years; 43 [47.3%] male patients; 11 [12.1%] Black and 76 [83.5%] White patients) had non–COVID-19 illness. Several patients were analyzed over multiple days. Among 94 positive samples, 41 samples were from patients in 2021 infected with the Delta or other variants, and 53 samples were from patients in 2022 infected with the Omicron variant, based on the State of Michigan and US Centers for Disease Control and Prevention surveillance data. Four VOC biomarkers were found to distinguish between COVID-19 (Delta and other 2021 variants) and non–COVID-19 illness with an accuracy of 94.7%. However, accuracy dropped substantially to 82.1% when these biomarkers were applied to the Omicron variant. Four new VOC biomarkers were found to distinguish the Omicron variant and non–COVID-19 illness (accuracy, 90.9%). Breath analysis distinguished Omicron from the earlier variants with an accuracy of 91.5% and COVID-19 (all SARS-CoV-2 variants) vs non–COVID-19 illness with 90.2% accuracy. Conclusions and Relevance The findings of this diagnostic study suggest that breath analysis has promise for COVID-19 detection. However, similar to rapid antigen testing, the emergence of new variants poses diagnostic challenges. The results of this study warrant additional evaluation on how to overcome these challenges to use breath analysis to improve the diagnosis and care of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Volatile Organic CompoundsUnited StatesAdultHumansMaleMiddle AgedFemaleSARS-CoV-2Breath Tests

Substanzen

Volatile Organic Compounds

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Michigan, Ann Arbor.
  • Max Harry Weil Institute for Critical Care Research and Innovation, University of Michigan, Ann Arbor.
  • Department of Electrical Engineering and Computer Science, University of Michigan, Ann Arbor.
  • Department of Internal Medicine, Division of Pulmonary Critical Care Medicine, University of Michigan, Ann Arbor.
  • Department of Emergency Medicine, University of Michigan, Ann Arbor.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Sharma, R., Zang, W., Tabartehfarahani, A., Lam, A., Huang, X., Sivakumar, A. D., Thota, C., Yang, S., Dickson, R. P., Sjoding, M. W., Bisco, E., Mahmood, C. C., Diaz, K. M., Sautter, N., Ansari, S., Ward, K. R., & Fan, X. (2023). Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.0982

Vancouver

Sharma R, Zang W, Tabartehfarahani A, Lam A, Huang X, Sivakumar AD, et al. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.0982

BibTeX
@article{Sharma2023,
  author = {Sharma, Ruchi and Zang, Wenzhe and Tabartehfarahani, Ali and Lam, Andres and Huang, Xiaheng and Sivakumar, Anjali Devi and Thota, Chandrakalavathi and Yang, Shuo and Dickson, Robert P and Sjoding, Michael W and Bisco, Erin and Mahmood, Carmen Colmenero and Diaz, Kristen Machado and Sautter, Nicholas and Ansari, Sardar and Ward, Kevin R and Fan, Xudong},
  title = {Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.0982}
}
Kostenlos starten →